These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9450506)
1. Human thiopurine methyltransferase: no evidence of activation by its substrates. Stupans I; Kirlich A; McKinnon RA Life Sci; 1998; 62(4):343-50. PubMed ID: 9450506 [TBL] [Abstract][Full Text] [Related]
2. Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism. Lennard L; Lilleyman JS Ther Drug Monit; 1996 Aug; 18(4):328-34. PubMed ID: 8857546 [TBL] [Abstract][Full Text] [Related]
3. Purine substrates for human thiopurine methyltransferase. Deininger M; Szumlanski CL; Otterness DM; Van Loon J; Ferber W; Weinshilboum RM Biochem Pharmacol; 1994 Nov; 48(11):2135-8. PubMed ID: 7802704 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in the pharmacogenomics of thiopurine methyltransferase. Coulthard SA; Hall AG Pharmacogenomics J; 2001; 1(4):254-61. PubMed ID: 11908768 [TBL] [Abstract][Full Text] [Related]
6. Methylation of 6-mercaptopurine and 6-thioguanine by thiopurine S-methyltransferase. A comparison of activity in red blood cell samples of 199 blood donors. Kröplin T; Iven H Eur J Clin Pharmacol; 2000 Jul; 56(4):343-5. PubMed ID: 10954350 [TBL] [Abstract][Full Text] [Related]
8. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity. Lennard L; Welch JC; Lilleyman JS Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462 [TBL] [Abstract][Full Text] [Related]
9. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells. Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220 [TBL] [Abstract][Full Text] [Related]
10. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease. Kwan LY; Devlin SM; Mirocha JM; Papadakis KA Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898 [TBL] [Abstract][Full Text] [Related]
11. Thiopurine S-methyltransferase activity in Japanese subjects: metabolic activity of 6-mercaptopurine 6-methylation in different TPMT genotypes. Nishida A; Kubota T; Yamada Y; Higashi K; Kitamura K; Nakahara K; Iga T Clin Chim Acta; 2002 Sep; 323(1-2):147-50. PubMed ID: 12135816 [TBL] [Abstract][Full Text] [Related]
12. Quantification of Thiopurine Metabolites in Human Erythrocytes by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Li L; Atkinson N; Crews KR; Molinelli AR Methods Mol Biol; 2024; 2737():443-452. PubMed ID: 38036845 [TBL] [Abstract][Full Text] [Related]
13. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells. Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272 [TBL] [Abstract][Full Text] [Related]
15. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase. Krynetski EY; Krynetskaia NF; Yanishevski Y; Evans WE Mol Pharmacol; 1995 Jun; 47(6):1141-7. PubMed ID: 7603453 [TBL] [Abstract][Full Text] [Related]
16. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Wielinga PR; Reid G; Challa EE; van der Heijden I; van Deemter L; de Haas M; Mol C; Kuil AJ; Groeneveld E; Schuetz JD; Brouwer C; De Abreu RA; Wijnholds J; Beijnen JH; Borst P Mol Pharmacol; 2002 Dec; 62(6):1321-31. PubMed ID: 12435799 [TBL] [Abstract][Full Text] [Related]
17. Comparison of 6-mercaptopurine with 6-thioguanine for the analysis of thiopurine S-methyltransferase activity in human erythrocyte by LC-MS/MS. Mei S; Li X; Gong X; Zhang X; Li X; Yang L; Zhu L; Zhou H; Liu Y; Zhou A; Zhang X; Zhao Z Biomed Chromatogr; 2017 Sep; 31(9):. PubMed ID: 28212467 [TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients. Gilissen LP; Bierau J; Derijks LJ; Bos LP; Hooymans PM; van Gennip A; Stockbrügger RW; Engels LG Aliment Pharmacol Ther; 2005 Oct; 22(7):605-11. PubMed ID: 16181300 [TBL] [Abstract][Full Text] [Related]
19. The effect of thiopurine drugs on DNA methylation in relation to TPMT expression. Hogarth LA; Redfern CP; Teodoridis JM; Hall AG; Anderson H; Case MC; Coulthard SA Biochem Pharmacol; 2008 Oct; 76(8):1024-35. PubMed ID: 18708030 [TBL] [Abstract][Full Text] [Related]
20. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. Evans WE; Horner M; Chu YQ; Kalwinsky D; Roberts WM J Pediatr; 1991 Dec; 119(6):985-9. PubMed ID: 1960624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]